🔴 Veraxa Biotech is trading 5.9% down in pre-market following a sharp rally during prior sessions

Veraxa Biotech is trading at $1.66 (-5.93%) after a sharp rally during prior sessions.

• The stock declined from the $1.76 September 7 close.
• No new September 8 company-specific announcement or major catalyst was identified; latest reported developments were the September 4 CFO appointment and a filing for up to 25 million shares by selling stockholders.
• Broader sentiment is cautious, with major U.S. indices lower pre-market, but the decline cannot be directly attributed to macro conditions.